Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750463 · ClinicalTrials.gov registry record
Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 65
- Enrollment target
NCT01750463 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 65 participants.
The verdict
NCT01750463 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
This is a prospective study to determine the accuracy of the Masimo Pronto Non-Invasive Hemoglobin Monitor and associated Rainbow® probes in the detection of hemoglobin concentration in critically ill children.
Interventions
- OTHER Masimo Pronto Rad 7 Non-Invasive hemoglobin monitor
- OTHER Standard Laboratory Blood Draw and Hemoglobin Analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01750463
The ClinicalTrials.gov registry entry for NCT01750463 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Masimo Pronto Rad 7 Non-Invasive hemoglobin monitor is the first listed.
NCT01750463 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01750463 about?
NCT01750463 is a clinical study titled "Comparing Validity of Non-Invasive Hemoglobin Monitoring to Laboratory Results in Critically Ill Children". This is a prospective study to determine the accuracy of the Masimo Pronto Non-Invasive Hemoglobin Monitor and associated Rainbow® probes in the detection of hemoglobin concentration in critically ill children.
What is the current status of trial NCT01750463?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2013-01. Estimated completion is 2013-05.
What interventions are being tested in trial NCT01750463?
The interventions under investigation include: Masimo Pronto Rad 7 Non-Invasive hemoglobin monitor (OTHER), Standard Laboratory Blood Draw and Hemoglobin Analysis (OTHER).
Who is sponsoring clinical trial NCT01750463?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.